These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20434013)

  • 21. Flow cytometric analysis of cell membrane microparticles.
    Gelderman MP; Simak J
    Methods Mol Biol; 2008; 484():79-93. PubMed ID: 18592174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High concentrations of procoagulant microparticles in the cerebrospinal fluid and peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome.
    Huang M; Hu YY; Dong XQ
    Surg Neurol; 2009 Nov; 72(5):481-9; discussion 489. PubMed ID: 19328537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated thrombosis.
    Furie B; Furie BC
    Blood Cells Mol Dis; 2006; 36(2):177-81. PubMed ID: 16490369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revisited role of microparticles in arterial and venous thrombosis.
    Lacroix R; Dubois C; Leroyer AS; Sabatier F; Dignat-George F
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():24-35. PubMed ID: 23809108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microparticle analysis in disorders of hemostasis and thrombosis.
    Mooberry MJ; Key NS
    Cytometry A; 2016 Feb; 89(2):111-22. PubMed ID: 25704723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flamethrowers: blood cells and cancer thrombosis risk.
    Pabinger I; Posch F
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):410-7. PubMed ID: 25696887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tissue factor-exposing microparticles.
    Lechner D; Weltermann A
    Thromb Res; 2008; 122 Suppl 1():S47-54. PubMed ID: 18691500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
    Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
    Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of tissue factor in hemostasis and thrombosis.
    Mackman N
    Blood Cells Mol Dis; 2006; 36(2):104-7. PubMed ID: 16466951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microparticles in cancer.
    Rak J
    Semin Thromb Hemost; 2010 Nov; 36(8):888-906. PubMed ID: 21049390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-derived microparticles: a new challenge in neuroscience.
    Doeuvre L; Plawinski L; Toti F; Anglés-Cano E
    J Neurochem; 2009 Jul; 110(2):457-68. PubMed ID: 19457085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-derived microparticles in haemostasis and vascular medicine.
    Burnier L; Fontana P; Kwak BR; Angelillo-Scherrer A
    Thromb Haemost; 2009 Mar; 101(3):439-51. PubMed ID: 19277403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated thrombosis.
    Zwicker JI; Furie BC; Furie B
    Crit Rev Oncol Hematol; 2007 May; 62(2):126-36. PubMed ID: 17293122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
    van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus.
    Nomura S; Inami N; Shouzu A; Urase F; Maeda Y
    Platelets; 2009 Sep; 20(6):406-14. PubMed ID: 19658004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats.
    Mortaza S; Martinez MC; Baron-Menguy C; Burban M; de la Bourdonnaye M; Fizanne L; Pierrot M; Calès P; Henrion D; Andriantsitohaina R; Mercat A; Asfar P; Meziani F
    Crit Care Med; 2009 Jun; 37(6):2045-50. PubMed ID: 19384196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression.
    Castellana D; Kunzelmann C; Freyssinet JM
    Hamostaseologie; 2009 Jan; 29(1):51-7. PubMed ID: 19151847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived microparticles and coagulation activation in breast cancer patients.
    Toth B; Liebhardt S; Steinig K; Ditsch N; Rank A; Bauerfeind I; Spannagl M; Friese K; Reininger AJ
    Thromb Haemost; 2008 Oct; 100(4):663-9. PubMed ID: 18841290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Circulating endothelial microparticles: a new marker of vascular injury].
    Boulanger CM; Leroyer AS; Amabile N; Tedgui A
    Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):149-54. PubMed ID: 18579117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools.
    Rubin O; Crettaz D; Canellini G; Tissot JD; Lion N
    Vox Sang; 2008 Nov; 95(4):288-97. PubMed ID: 19138258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.